Why the study?
Standard exercise testing and stress echoes have limitations in hypertrophic cardiomyopathy due to characteristic ECG changes and wall motion abnormalities, emphasizing the need to define the role of CPET.
Does cardiopulmonary exercise testing improve functional assessment and risk stratification in patients with hypertrophic cardiomyopathy compared to standard stress testing?
Does cardiopulmonary exercise testing improve functional assessment and risk stratification in patients with hypertrophic cardiomyopathy compared to standard stress testing?
Answers are grounded in this paper and cite their sources.
Cardiopulmonary exercise testing is a critical tool for the comprehensive evaluation, risk stratification, and management of patients with hypertrophic cardiomyopathy.
This review emphasizes the importance of cardiopulmonary exercise testing (CPET) in patients diagnosed with hypertrophic cardiomyopathy (HCM). In contrast to standard exercise testing and stress echoes, which are limited due to the ECG changes and wall motion abnormalities that characterize this condition, CPET allows for the assessment of the complex pathophysiology and severity of the disease, its mechanisms of functional limitation, and its risk stratification. It is useful tool to evaluate the risk for sudden cardiac death and select patients for cardiac resynchronization therapy (CRT), cardiac transplantation, or mechanical circulatory support, especially when symptomatology and functional status are uncertain. It may help in differentiating HCM from other forms of cardiac hypertrophy, such as athletes' heart. Finally, it is used to guide and monitor therapy as well as for exercise prescription. It may be considered every 2 years in clinically stable patients or every year in patients with worsening symptoms. Although performed only in specialized centers, CPET combined with echocardiography (i.e., CPET imaging) and invasive CPET are more informative and provide a better assessment of cardiac functional status, left ventricular outflow tract obstruction, and diastolic dysfunction during exercise in patients with HCM.
No takes yet. Share an insight, caveat, or question.
Mikic et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: